logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
D

Dolores Isla

Hospital Clínico Universitario Lozano Blesa
H指数:43
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Soluble Immune Checkpoints as Prognostic Biomarkers in Small Cell Lung Cancer Patients Treated with Chemotherapy and Anti-PD-L1

可溶性免疫检查点作为接受化疗和抗PD-L1治疗的小细胞肺癌患者的预后生物标志物

International Journal of Molecular Sciences
IF4.9
2026-08-120
OA
Albert Guinart-Cuadra; Aida Piedra; Sergio Martínez-Recio; Maria Mulet; Carlos Zamora; Rubén Osuna-Gómez; Elisabet Cantó; Maria Angels Ortiz; Andrés Barba; Judit Sanz-Beltran; Jorgina Serra-López; Luís Paz-Ares; Edurne Arriola; Alberto Luis Moreno; Rosario Garcia-Campelo; Cristina Martí-Blanco; Dolores Isla; Ángel Callejo; Margarita Majem; Silvia Vidal
Efficacy and safety of subcutaneous and intravenous administration of atezolizumab in patients with non-small cell lung cancer, including early-stage, locally advanced or metastatic disease: Updated results of the IMscin001 and IMscin002 randomized studies

非小细胞肺癌患者皮下和静脉注射阿替利珠单抗的疗效与安全性，包括早期、局部晚期或转移性疾病：IMscin001和IMscin002随机研究的更新结果

Lung Cancer
IF4.4
2026-05-120
OAAI
Mauricio Burotto; Zanete Zvirbule; Renzo Alvarez; Busyamas Chewaskulyong; Enriqueta Felip; Margarita Majem; Ernesto Korbenfeld; Jaroslaw Kolb-Sielecki; Dolores Isla; Teresa Barata; Alberto Bustillos; Luis A. Herraez-Baranda; Nadia Tosti; Fiona Young; James Zanghi; Federico Cappuzzo
Brief report: Artificial intelligence meets small cell lung cancer—integrating clinicopathological and wholeslide image data for prognostic prediction in SCLC

简要报告: 人工智能与小细胞肺癌相遇-整合临床病理和整体影像数据以预测SCLC的预后

Frontiers in Artificial Intelligence
IF4.7
2026-04-200
OA
PR Pedro Rocha †; JG Joan Gibert †; SM Silvía Menendez; RD Raúl del Rey-Vergara; AI Albert Iñañez; LM Laura Masfarré; NN Nil Navarro; AR Alejandro Ríos-Hoyo; SP Sandra Perez; ÁT Álvaro Taus; MG Mario Giner; AR Ana Rovira; LL Luis León-Mateos; DI Dolores Isla; LP Luis Paz-Ares; JZ Jon Zugazagoitia; CM Cristina Martí Blanco; RG Rosario García-Campelo; AM Alberto Moreno-Vega; ÁC Ángel Callejo; FR Federico Rojo; IS Ignacio Sanchéz; EA Edurne Arriola
Baseline PD-L1 expression on circulating immune cells as a predictor of survival and immune-related adverse events in extensive-stage small-cell lung cancer patients treated with durvalumab and carboplatin-etoposide (NCT04712903 Trial)

基线时循环免疫细胞中PD-L1的表达作为接受度鲁鲁单抗联合卡铂-足叶乙苷治疗广泛期小细胞肺癌患者生存和免疫相关不良事件的预测因子（NCT04712903试验）

Journal of Translational Medicine
IF7.5
2026-02-280
OAAI
Aida Piedra; Albert Guinart-Cuadra; Sergio Martínez-Recio; Maria Mulet; Carlos Zamora; Rubén Osuna-Gómez; Elisabet Cantó; Maria Angels Ortiz; José Alejandre; Andrés Barba; Judit Sanz-Beltrán; Jorgina Serra-López; Dolores Isla; Edurne Arriola; Luis Paz-Ares; María Pilar Diz-Taín; Alberto Luis Moreno; Ángel Callejo; Silvia Vidal; Margarita Majem
Durvalumab plus platinum-etoposide in the first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A single-arm clinical trial

度伐利尤单抗联合铂类-依托泊苷在广泛期小细胞肺癌一线治疗中的应用（CANTABRICO）：一项单臂临床试验

Lung Cancer
IF4.4
2025-09-240
PRE
Dolores Isla; Jon Zugazagoitia; Edurne Arriola; Rosario García-Campelo; Cristina Martí Blanco; María Pilar Diz-Taín; Marta López-Brea; Alberto Luis Moreno-Vega; Luis León-Mateos; Juana Oramás; Vanesa Gutiérrez-Calderón; Margarita Majem; Alfredo Sánchez-Hernández; Carlos Aguado; Ruth Alvarez-Cabellos; Bartomeu Massutí; Amaia Moreno; José-Luis Fírvida-Pérez; Javier Valdivia; Marta González-Cordero; Marta Zafra-Poves; Manuel Dómine; Francisco Javier Garcia-Navalon; Noemí Villanueva; Mariano Provencio; Oscar Juan-Vidal; Carlos Rivas-Corredor; María Eugenia Olmedo García; Ramón Palmero; Rafael López-Castro; Enric Carcereny; José Luis Lechuga; Marta Domínguez; Ángel Callejo; Luis Paz-Ares
MET pathway inhibition increases chemo-immunotherapy efficacy in small cell lung cancer

MET通路抑制可增强小细胞肺癌的化疗-免疫治疗疗效

Cell Reports Medicine
IF10.6
2025-06-200
OAAI
Raúl del Rey-Vergara; Miguel Alejandro Galindo-Campos; Pedro Rocha; Marina Carpes; Carlos Martínez; Laura Masfarré; Silvia Menéndez; Fabricio Quimis; Adrià Rossell; Albert Iñañez; Sandra Pérez-Buira; Federico Rojo; Ramon Gimeno; Dolores Isla; Jon Zugazagoitia; Cristina Martí Blanco; Rosario García-Campelo; Alberto Moreno-Vega; Luis León-Mateos; Ángel Callejo Mellén; Kwon-Sik Park; Simon Heeke; John V. Heymach; Álvaro Taus; Luis Paz-Ares; Ana Rovira; Edurne Arriola
Prevalence of EGFR gene mutations in patients with early-stage resectable non-small cell lung cancer in Spain: the ORIGEN study

西班牙早期可切除非小细胞肺癌患者中EGFR基因突变的发生率：ORIGEN研究

TRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
2025-04-010
OA
Varela, Mar; Teixido, Cristina; Alvarez-Fernandez, Carlos; Arasanz, Hugo; Peralta, Sergio; Lazaro, Martin; Calvo, Virginia; Alvarez, Rosa; Baena, Javier; Valdivia, Javier; Arriola, Edurne; Bernabe, Reyes; Isla, Dolores; Camacho, Carmen; Massuti, Bartomeu; Blasco, Ana; Garcia, Teresa; Cobo, Manuel; Campayo, Marc; Hijazo-Pechero, Sara; Callejo, Angel; Dominguez, Marta
Primary Results from IMscin002: A Study to Evaluate Patient Preferences and Perceptions of Health Care Professionals for Atezolizumab Subcutaneous Versus Intravenous for the Treatment of NSCLC

IMscin002研究的主要结果：一项评估患者对阿替利珠单抗皮下注射与静脉注射治疗NSCLC的偏好及对医疗专业人员的看法的研究。

JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2025-02-010
OAAI
Cappuzzo, Federico; Zvirbule, Zanete; Korbenfeld, Ernesto; Kolb-Sielecki, Jaroslaw; Isla, Dolores; Szczesna, Aleksandra; Sanchez, Amparo Yovanna Castro; Bustillos, Alberto; Young, Fiona; Tosti, Nadia; Monteiro, Marta Freitas; Majem, Margarita
First-line pembrolizumab in patients with advanced non-small cell lung cancer and high PD-L1 expression: real-world data from a Spanish multicenter study
FRONTIERS IN ONCOLOGY
IF3.3
2024-12-170
OAAI
Piedra, Aida; Martinez-Recio, Sergio; Hernandez, Ainhoa; Moran, Teresa; Arriola, Edurne; Recuero-Borau, Jordi; Cobo, Manuel; Cordeiro, Patricia; Mosquera, Joaquin; Fernandez, Manuel; Garcia-Campelo, Rosario; Calles, Antonio; Alvarez, Rosa; Zapata-Garcia, Maria; Isla, Dolores; Callejo, Ana; Iranzo, Patricia; Serra-Lopez, Jorgina; Barba, Andres; Sullivan, Ivana; Felip, Enriqueta; Majem, Margarita
Impact of antibiotics, corticosteroids, and microbiota on immunotherapy efficacy in patients with non-small cell lung cancer

抗生素、糖皮质激素和微生物对非小细胞肺癌患者免疫治疗疗效的影响

HELIYON
IF3.6
2024-07-012
OAAI
Zapata-Garcia, Maria; Moratiel-Pellitero, Alba; Isla, Dolores; Galvez, Eva; Gascon-Ruiz, Marta; Sesma, Andrea; Barbero, Raquel; Galeano, Javier; del Campo, Rosa; Ocariz, Maitane; Quilez, Elisa; Cruellas, Mara; Pardo, Julian; Martinez-Lostao, Luis; Domingo, Maria Pilar; Esteban, Patricia; Torres-Ramon, Irene; Yubero, Alfonso; Pano, Jose Ramon; Lastra, Rodrigo
Phase IIIb study of durvalumab plus platinumeetoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): Treatment patterns of chemotherapy combination phase with durvalumab
ANNALS OF ONCOLOGY
IF65.4
2022-04-010
OA
Isla, D.; Arriola, E.; Garcia Campelo, M. R.; Marti, C.; Diz Tain, P.; Moreno Vega, A. L.; Piqueras, M. L-B.; Leon, L.; Gutierrez Calderon, V.; Oramas Rodriguez, J. M.; Majem, M.; Sanchez-Hernandez, A.; Aguado de la Rosa, C.; Alvarez Cabellos, R.; Marti-Ciriquian, J. L.; Moreno Paul, A.; Gonzalez Cordero, M.; Callejo Mellen, A.; Baez, L.; Zugazagoitia, J.
VP3-2022: Pembrolizumab (pembro) versus placebo for early-stage non-small cell lung cancer (NSCLC) following complete resection and adjuvant chemotherapy (chemo) when indicated: Randomized, triple-blind, phase III EORTC-1416-LCG/ETOP 8-15 e PEARLS/KEYNOTE-091 study
ANNALS OF ONCOLOGY
IF65.4
2022-04-0162
OAAI
Paz-Ares, L.; O'Brien, M. E. R.; Mauer, M.; Dafni, U.; Oselin, K.; Havel, L.; Gonzalez, E. Esteban; Isla, D.; Martinez-Marti, A.; Faehling, M.; Tsuboi, M.; Lee, J-s.; Nakagawa, K.; Yang, J.; Keller, S. M.; Jha, N.; Marreaud, S. I.; Stahel, R. A.; Peters, S.; Besse, B.
Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis

免疫检查点抑制剂联合化疗与单纯化疗作为广泛期小细胞肺癌的一线治疗: 一项系统综述和荟萃分析

ONCOLOGY AND THERAPY
IF3.2
2022-01-1516
OAAI
Arriola, Edurne; Gonzalez-Cao, Maria; Domine, Manuel; De Castro, Javier; Cobo, Manuel; Bernabe, Reyes; Navarro, Alejandro; Sullivan, Ivana; Manuel Trigo, Jose; Mosquera, Joaquin; Crama, Leonardo; Isla, Dolores

研究方向

暂未获取到该数据
M
Margarita Majem
H 指数:55论文数:536被引数:2.4万
M
Manuel Cobo
H 指数:57论文数:524被引数:2.8万
R
Rafael Rosell
H 指数:55论文数:283被引数:2.4万
E
Edurne Arriola
H 指数:35论文数:257被引数:3,815
L
Luis Paz‐Ares
H 指数:116论文数:1,393被引数:9.4万
C
Carlos Camps
H 指数:57论文数:628被引数:1.6万
B
Bartomeu Massutí
H 指数:56论文数:432被引数:2.0万
T
Teresa Morán
H 指数:49论文数:392被引数:1.8万
E
Enriqueta Felip
H 指数:129论文数:1,499被引数:11.1万
M
Mariano Provencio
H 指数:73论文数:1,036被引数:2.8万